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Surgical Outcomes of Transconjunctival Anterior Orbitotomy 
for Intraconal Orbital Cavernous Hemangioma
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Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, 
The Catholic University of Korea School of Medicine, Seoul, Korea
Purpose: To describe surgical outcomes for transconjunctival anterior orbitotomy for intraconal cavernous 
hemangiomas. 
Methods: The medical records of 9 consecutive patients with intraconal cavernous hemangiomas who underwent 
surgical removal by transconjunctival anterior orbitotomy were retrospectively reviewed. The conjunctiva was in-
cised and retracted with a traction suture. For large tumors, a rectus muscle was temporarily disinserted. Tenon’s 
capsule was separated and the tumor was removed with a cryoprobe or clamp. Surgical outcomes, positions of 
the tumors, methods of approach, and intra- and post-operative complications were evaluated.
Results: The mean follow-up period was 33 ± 6.8 months. No bony orbitotomy was used in this technique and the 
cosmetic results were very satisfactory. All tumors were removed intact. In 4 patients, tumors were extirpated 
with the aid of a cryoprobe. No patients had residual proptosis or limitation of ocular movement. No signs of re-
currence were noted in any cases at 33 months follow-up. No serious or permanent complications were observed 
during or after the operation.
Conclusions: Transconjunctival anterior orbitotomy is an important surgical procedure in the treatment of intraconal 
cavernous hemangiomas. It can produce an excellent result, even if the posterior border of the tumor abuts the 
orbital apex.
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Cavernous hemangiomas are relatively common benign 
tumors of the orbit, and the second most frequent cause of 
unilateral proptosis after thyroid-related orbitopathy [1-3]. 
Although benign histopathologically, a cavernous hemangio-
ma may often cause proptosis and interfere with optic nerve 
function, necessitating surgical intervention. Most of these 
tumors are located within the intraconal space, so lateral or-
bitotomy [4] or anterior orbitotomy [5,6]
 are the preferred 
methods of surgical removal. Lateral orbitotomy offers a 
wide surgical field; however, it requires a skin incision, re-
moval of bone tissue, and anatomical reconstruction. 
Additionally, if the mass is on the medial aspect of the optic 
nerve the approach must pass by the optic nerve, increasing 
the risk of optic nerve damage. Transconjunctival anterior 
orbitotomy (TCAO) is better from a cosmetic perspective 
and saves time compared to a lateral orbitotomy with bony 
orbitotomy. TCAO also has a low risk of optic nerve damage 
because the conjunctival incision can be made according to 
the location of the mass. In general, the transconjunctival 
approach to the orbit has been under-utilized because of 
concern regarding inadequate exposure and postoperative 
complications, especially when the posterior border of the 
mass abuts the orbital apex. However, if the characteristics 
of a cavernous hemangioma are considered, such as encap-
sulation by a fibrous capsule, TCAO can be utilized in many 
more cases. The purpose of this study is to describe our sur-
gical outcomes and discuss the advantages and dis-
advantages of TCAO for intraconal cavernous hemangio-
mas (ICCHs).
Materials and Methods
We reviewed the medical records of all patients who un-KJ Cho, et al. Transconjunctival Anterior Orbitotomy
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Table 1. Patient data, primary findings, surgical procedures, and outcomes
Case 
no.
Sex/age
(yr)
Position
of mass
Size of mass
(cm)
Chief
complaint Surgical procedures
Proptosis
(mm)
* LOM Visual acuity
Preop Preop 3 Mo. 6 Mo. Preop Postop
1 F/32 Intraconal 
Superonasal
2.5×2.0 Proptosis   TCAO 
  SRM disinsertion
  Cryoprobe
6.0 No Yes No 1.0 1.0
2 F/27 Intraconal   
Nasal
2.8×2.0 Proptosis   TCAO
  MRM disinsertion
  Hemostat
3.0 No No No 1.0 1.0
3 F/49 2.3×2.2 Diplopia   TCAO
  Hemostat
2.0 Yes No No 1.0 0.8
4 F/61 Intraconal   
Inferotemporal
2.2×1.8 Proptosis   TCAO
  IRM disinsertion
  Cryoprobe
0N o Y e s N o 1 . 0 1 . 0
5 F/60 1.8×1.6 Lump 
at lower lid
  TCAO
  Cryoprobe
0 Yes No No 1.0 1.0
6 F/47 Intraconal   
Inferior
1.1×1.0 Lump 
at lower lid
  TCAO
  Lateral canthotomy
  Hemostat
0N o N o N o 1 . 0 1 . 0
7 F/36 3.5×3.0 Proptosis   TCAO
  Lateral canthotomy
  Hemostat
12.0 Yes No No F/C 
50 cm
0.06
8 F/36 Intraconal   
Inferonasal
2.5×1.5 Proptosis   TCAO
  MRM disinsertion
  Cryoprobe
5.0 Yes No No 0.63 0.8
9 M/20 2.0×1.3 Proptosis   TCAO
  Cryoprobe
0N o N o N o 1 . 0 1 . 0
LOM = limitation of ocular movement; Preop = preoperative; Postop = postoperative; Mo. = months later; TCAO = transconjunctival 
anterior orbitotomy; SRM = superior rectus muscle; MRM = medial rectus muscle; IRM = inferior rectus muscle; Cryoprobe = extraction 
with cryoprobe; Hemostat = extraction with hemostat.
*No patients exhibited proptosis postoperatively.
derwent TCAO for ICCH at Seoul St. Mary’s Hospital between 
June 1998 and May 2006 by a single surgeon. Indications 
for the surgery included compression of the optic nerve, 
proptosis, or limited ocular movements with preoperative 
diplopia. All identified cases were histologically diagnosed 
as cavernous hemangiomas. A detailed ocular history and 
ophthalmological examination were performed. The pa-
tients underwent both B-scan ultrasonography and com-
puted tomography (or magnetic resonance imaging) before 
surgery. The mean follow-up period was 33 ± 6.8 months.
All 9 patients underwent TCAO to remove an ICCH. 
After spreading the eyelids apart, the conjunctiva was in-
cised at the location of the mass. The resulting flap was 
opened in a caudal direction. The conjunctiva was then re-
tracted and traction sutures were placed under at least 2 rec-
tus muscles to guide the globe in the desired direction to 
reach the retrobulbar space. For large tumors, it was often 
necessary to temporarily disinsert a rectus muscle, depend-
ing on the location of the tumor (Table 1). Next, Tenon’s 
capsule was separated from the sclera with cotton-tip appli-
cators and the anterior tip of the tumor was exposed (Fig. 
1A). If the tumor was relatively mobile, the anterior portion 
was frozen with a standard retinal cryoprobe and pulled out 
gently (4 cases, Fig. 1B). In other instances, the tumor was 
removed by grasping the tip with a clamp, separating the 
mass from the sclera with cotton-tip applicators, and slowly 
pulling out with rotating movements (5 cases). After com-
plete removal, the rectus muscle was reinserted and the con-
junctiva was sutured into its original position. Two patients 
underwent a transconjunctival incision combined with a 
lateral canthotomy to gain access to cavernous hemangio-
mas that were deeper and closer to the inferior orbital wall. 
The position and size of the masses and the methods of sur-
gical approach are shown in Table 1. In 2 patients, the poste-
rior border of the tumor abutted the orbital apex (Fig. 2D).
Clinical ophthalmological evaluation included assess-
ment of visual acuity, exophthalmos (Hertel exophthal-
mometer), ocular motility, color perception test (Ishihara 
color plates), biomicroscopy of the anterior segment, ki-
netic perimetry (Humphrey), and measurements of intra-
ocular pressure using Goldman’s tonometer, followed by 
dilated examination of the fundus. This protocol was per-
formed before the operation, at 1 and 2 weeks after the oper-
ation, and then at 3 months intervals. 
Results
Eight patients were female and 1 was male. The average Korean J Ophthalmol Vol.24, No.5, 2010
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Fig. 1. Preoperative computed tomography (CT) and magnetic resonance imaging (MRI). (A) Axial CT (mass is ovoid in shape and sharply 
delineated). (B) Coronal T2-weighted MRI (intraconal mass at the medial portion of the left orbit). (C) Axial T2-weighted MRI (intraconal 
mass at the inferolateral portion of the left orbit). (D) Axial T2-weighted MRI (lesion immediately behind the eyeball causing flattening of the 
globe). 
age was 40.9 ± 14.3 (range, 20 to 61 years). The presenting 
symptoms are shown in Table 1. The most common com-
plaint was a painless, gradually progressive proptosis (6 
cases) lasting for an average of 48 months (range, 1 to 120 
months). The average amount of proptosis was 5.6 mm 
(range, 2.0 to 12.0 mm). Diplopia or limitation of ocular 
movement (LOM) was the second most common symptom 
(4 cases). Other less common symptoms included a lump of 
the lower lid (2 cases) and decreased visual acuity (2 cases). 
Clinical signs at presentation included strabismus (4 cases), 
a pale optic disc (1 case), papilledema with a relative affer-
ent pupillary defect (1 case), and a protruding mass of the 
lower lid (2 cases). 
Orbital cavernous hemangiomas usually exhibit charac-
teristic features on B-scan ultrasonograms, computed to-
mography (CT)-scans, and magnetic resonance images. 
The B-scan ultrasonograms of all patients showed high in-
ternal reflectivity of a round orbital mass. The CT and mag-
netic resonance imaging (MRI) displayed well-circum-
scribed masses that were round or ovoid in shape and sharp-
ly delineated from the surrounding tissue (Fig. 2). The tu-
mors were isointense with brain tissue on T1-weighted im-
ages and hyperintense on T2-weighted images. The tumors 
did not alter the orbital bone contours in any of the cases. 
Lesions immediately behind the eyeball caused flattening 
of the globe, leading to choroidal atrophy, a pale optic disc, 
or papilledema in 2 cases (Fig. 2D). 
All tumors were completely removed. No patient had any 
residual proptosis. Two patients who had presented with de-
creased visual acuity showed postoperative improvements 
which remained stable after 29 months of follow-up. None 
of the patients' visual acuity worsened. Diplopia or LOM re-
solved spontaneously in all 4 patients in whom ocular 
movements were limited preoperatively. Two patients who 
did not have diplopia or LOM preoperatively exhibited 
LOM postoperatively; however, this was improved at 6 
months follow-up. The cavernous hemangiomas exhibited a 
typical gross appearance. The tumors had a round or oval 
shape, were completely encapsulated, and possessed a typi-
cal dark red or purple color (Fig. 1C and 1D). The tumors 
were all easily dissected from the surrounding tissue and re-
moved with little adherence to other structures.
Discussion
Cavernous hemangiomas are one of the most common KJ Cho, et al. Transconjunctival Anterior Orbitotomy
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Fig. 2. Surgical procedures. (A) Anterior orbitotomy (transconjunctival incision). (B) Extraction of the mass with a cryoprobe. (C,D) Tumor 
mass (completely encapsulated, dark red or purple in color).
benign tumors of the orbit and are classified as congenital 
low-flow vascular malformations [1-3]. In our series, females 
were more likely to be affected than males (female:male = 
8:1). A similar preponderance was found by Harris and 
Jakobiec [7] who reported that 70% of their patients were 
women. The mean age of our patients was 40.9 (range, 20 to 
61 years), which was similar to the series of McNab and 
Wright [8] and Harris and Jakobiec [7] with mean ages of 42 
years (range, 18 to 67) and 47.8 years (range, 19 to 72), 
respectively. Left eyes were affected more commonly than 
right eyes (left : right = 6 : 3). This result was also similar to 
that of McNab and Wright [8] (left : right = 51 : 34). The 
most common complaint was painless, gradually progressive 
proptosis (n = 6).
Several surgical methods have been attempted since 
Asregadoo [9] successfully excised a cavernous hemangio-
ma using the Naffziger approach. Lateral orbitotomy [10] 
and anterior orbitotomy using a transcutaneous or trans-
conjunctival approach [6] have been the preferred methods. 
Lateral orbitotomy offers a wide operative field; however, it 
requires a skin incision, removal of bone tissue, and ana-
tomical reconstruction. This surgery is also time-consum-
ing and leaves a scar. 
An ICCH is typically surrounded by a fibrous capsule and 
composed of large, dilated vascular spaces lined by flat-
tened endothelial cells and fibrous interstitial tissue; also, 
they do not have a prominent blood supply [11].
 This unique 
structure makes ICCHs suitable for TCAO. In our series all 
9 patients underwent TCAO. All tumors were completely 
removed and no signs of recurrence were noted during the 
mean follow-up period of 33 months. Both immediate and 
long-term morphological and aesthetic results were good in 
all patients. No patient exhibited any residual proptosis. 
LOM resolved spontaneously in all 4 patients in whom ocu-
lar movements were limited preoperatively. Two patients 
who did not have diplopia or LOM preoperatively exhibited 
LOM postoperatively; however, this had improved at 6 
months follow-up. These immediate postoperative compli-
cations of diplopia or LOM may have been caused by 
over-retraction of thick fat tissue protruding into the oper-
ative field. No other immediate or long-term complications 
were encountered.
In general, the transconjunctival approach to the orbit has 
been under-utilized because of concern regarding in-
adequate exposure and postoperative complications such as 
lower eyelid shortening and ectropion. However, this ap-
proach offers several advantages compared to conventional 
methods. The transconjunctival approach provides ex-Korean J Ophthalmol Vol.24, No.5, 2010
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cellent exposure of the orbit, leaves no visible scar, pos-
sesses a lower risk of the complications associated with 
transcutaneous techniques such as nerve or muscle damage, 
and allows for a shorter operation time (usually 30 to 40 mi-
nutes) compared to other techniques. Despite these advan-
tages, this approach cannot be used in cases where the tu-
mor margin is ill-defined, adhesions are present, or the risk 
of malignant changes exists. Current imaging modalities 
and in particular, MRI, allow for relatively high accuracy in 
making the diagnosis of orbital cavernous hemangioma at 
the preoperative stage, making precise surgical planning 
possible.
Reviewing the literature, we found that many surgeons 
use the extensive surgical procedure of transcranial superior 
orbitotomy, especially when the posterior border of the 
mass abuts the orbital apex. TCAO could be used in these 
cases if the anterior part of the tumor is found immediately 
behind the globe. In fact, in 2 of our patients the posterior 
border of the tumor abutted the orbital apex. Additionally, 
the transconjunctival approach can be combined with later-
al canthotomy to increase exposure. McCord and Moses 
[12] obtained good results in the repair of orbital floor frac-
tures by using the transconjunctival approach combined 
with lateral canthotomy to increase exposure. We used a 
transconjunctival approach combined with lateral canthot-
omy to extract 2 masses that were either large (3.5 cm diam-
eter) or near the orbital rim. 
Surgeons are primarily concerned with two points when 
planning to remove a mass from the orbital cavity. The first 
is total removal of the tumor and the second is achieving the 
best possible cosmetic result. Given the development of 
minimally invasive surgery and better microsurgical techni-
ques, cosmetic results have become more important to both 
patients and surgeons. Any injury affecting the bony struc-
tures of the orbit may cause serious and unexpected cos-
metic results. TCAO is not suitable for the removal of 
ICCHs in which the margins are ill-defined, adhesions are 
present, or the risk of malignant changes exist [13-15]. 
However, in other cases we believe TCAO should be con-
sidered the treatment of choice for removal of ICCHs.
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